Novo Nordisk CEO Mike Doustdar Talks Drug Sales
Bloomberg Talks
00:00
Why Novo Needs Complementary Products
Guy raises analysts' concerns about buying versus believing in current portfolio; Doustdar says acquisitions add options for different patient preferences like pills versus injections.
Play episode from 03:54
Transcript
